ProPhase Labs, Inc. Inventory, Gross
ProPhase Labs, Inc. (PRPH) had Inventory, Gross of $70.00 thousand as of 2025-12-31, per its 10-K filed 2026-06-01.
Financial Statements › Notes › Inventory, Gross
us-gaap:InventoryGross · last filed 2026-06-01
- 2025-12-31: Inventory, Gross $70.00K.
- 2024-12-31: Inventory, Gross $1.15M.
- 2023-12-31: Inventory, Gross $2.51M; Inventory, Gross as first filed $4.10M.
- 2022-12-31: Inventory, Gross $4.49M.
| Period end | Inventory, Gross | Inventory, Gross as first filed |
|---|---|---|
| 2025-12-31 | $70.00K 10-K · filed 2026-06-01 | |
| 2024-12-31 | $1.15M 10-K · filed 2026-06-01 | |
| 2023-12-31 | $2.51M 10-K · filed 2025-04-01 | $4.10M 10-K · filed 2024-03-29 |
| 2022-12-31 | $4.49M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $5.17M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $4.94M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $5.14M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $5.04M 10-K · filed 2023-03-29 | |
| 2020-12-31 | $3.21M 10-K · filed 2022-03-31 | |
| 2018-12-31 | $1.90M 10-K · filed 2019-03-26 | |
| 2018-09-30 | $2.72M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $2.39M 10-Q · filed 2018-08-20 | |
| 2018-03-31 | $2.01M 10-Q/A · filed 2018-08-20 | |
| 2017-12-31 | $1.53M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |